Research Article
Health Risk Assessment of Metals in Antidiabetic Herbal Preparations: A Safety Screening
Table 4
Incremental lifetime cancer risk (ILCR) of metals through the consumption of antidiabetic herbal preparations.
| | Drug code | ILCR | | Pb | Cr | Cd | Ni |
| | S 1 | 6.95 × 10−02 | 1.43 × 10−02 | 2.57 × 10−04 | 1.02 × 10−04 | | S 2 | 0 | 3.07 × 10−02 | 0 | 1.53 × 10−04 | | S 3 | 0 | 8.43 × 10−03 | 1.08 × 10−04 | 1.90 × 10−04 | | S 4 | 4.32 × 10−03 | 0 | 0 | 0 | | S 5 | 2.21 × 10−03 | 4.60 × 10−03 | 8.48 × 10−05 | 1.42 × 10−04 | | S 6 | 0 | 5.92 × 10−03 | 0 | 9.75 × 10−05 | | S 7 | 0 | 0 | 1.98 × 10−07 | 0 | | S 8 | 1.98 × 10−03 | 0 | 0 | 7.30 × 10−05 | | S 9 | 0 | 0 | 0 | 0 | | S 10 | 0 | 0 | 0 | 2.98 × 10−05 | | S 11 | 7.09 × 10−04 | 0 | 0 | 0 | | S 12 | 1.12 × 10−01 | 3.13 × 10−02 | 0 | 4.73 × 10−04 | | S 13 | 1.30 × 10−01 | 6.73 × 10−02 | 6.23 × 10−04 | 4.93 × 10−04 | | S 14 | 5.21 × 10−02 | 2.10 × 10−02 | 2.11 × 10−04 | 1.22 × 10−04 | | S 15 | 2.31 × 10−02 | 1.04 × 10−02 | 4.27 × 10−05 | 5.08 × 10−05 | | S 16 | 3.09 × 10−01 | 1.68 × 10−01 | 1.90 × 10−03 | 5.94 × 10−03 | | S 17 | 8.35 | 1.61 × 10−02 | 1.40 × 10−03 | 0 | | S 18 | 0 | 0 | 0 | 0 | | S 19 | 0 | 0 | 0 | 0 | | S 20 | 0 | 0 | 0 | 0 | | S 21 | 0 | 0 | 0 | 0 | | S 22 | 1.12 | 2.02 × 10−01 | 3.21 × 10−03 | 7.52E − 04 | | S 23 | 2.81 × 10−01 | 6.93 × 10−02 | 8.91 × 10−04 | 4.89E − 04 | | S 24 | 0 | 2.51 × 10−03 | 1.36 × 10−05 | 0 |
|
|
